Upload
vukhanh
View
217
Download
1
Embed Size (px)
Citation preview
Assessment of HILIC
Mode and Stationary
Phase for UHPLC/MS
Anne Mack Agilent Technologies
Applications Chemist
Pittcon 2012 March 12, 2012
Session 420 - Liquid Chromatography
1
Agenda
What is HILIC
How it is different than RPLC
How it works
HILIC Considerations
Method Development
Advantages & Disadvantages
Why HILIC works well with MS
Review ESI-MS Source
Application Example
2
What is HILIC
Hydrophilic Interaction Liquid Chromatography
A liquid chromatographic technique that has been in limited
used for a couple of decades
Uses a polar stationary phase such as silica, amino, mixed
mode, zwitterionic, etc.
Uses a water-miscible, non-polar mobile phase containing a
small amount of water (at least 2-3% by weight)
May use volatile buffers for compatibility with MS detection
Complements reversed phase chromatography (RPLC); retains
hydrophilic compounds and often reverses elution order
3
HILIC versus RPLC
RPLC
Non-polar stationary phase (e.g., C18)
Polar mobile phase (i.e., H20/CH3OH, H20/CH3CN, etc.)
Decrease retention by decreasing polarity of mobile phase
(e.g., increase CH3CN in mobile phase to decrease retention)
HILIC
Polar stationary phase (e.g., silica)
Polar mobile phase (i.e., H20/CH3CN)
Decrease retention by increasing polarity of mobile phase
(i.e., increase H2O in mobile phase to decrease retention)
4
HILIC Retention Mechanism on Silica Based
Columns
O O O O
H2O H2O
H2O H2O H2O
H2O
H2O H2O
- - - -
H2O
3
CH 2 CHCH 3
NH +
ACN
ACN ACN
ACN ACN
ACN ACN
ACN ACN ACN
3
CH 2 CHCH 3
NH +
1. Partitioning in and out of adsorbed water layer
2. Ion exchange with silanols
1.
2.
5
HILIC Method Development: Mobile Phase
Considerations
Organic solvent concentration
Solvent strength in HILIC mode:
THF < Acetone < CH3CN < IPA < EtOH < MeOH < H2O
H2O is the strongest solvent—need >2-3% H2O for hydration of silica
Ionic strength of buffer
Concentration of (salt) buffer
Different anions and cations may can also affect analyte retention
Type of buffer
Acetates, formates good, soluble in CH3CN—also MS friendly
Phosphates are bad due to low CH3CN solubility
6
HILIC Method Development: Common LC
Parameters
Type of stationary phase
Vary retention mechanism and selectivity
Mobile phase pH
Controls ionization of silica and analytes
Temperature
Increasing temperature will decrease retention
Increasing temperature will increase column efficiency
Decreasing temperature can improve selectivity
7
Advantages of HILIC
Retention of polar compounds that would be unretained by RPLC
Complimentary selectivity to RPLC
Good peak shape for basic compounds where RPLC may give tailing or low efficiency
Higher flow rates, long columns can be used due to low viscosity mobile phases with high organic content; greater efficiency
Can simplify sample preparations
SPE, liquid/liquid extraction often end up in high organic mobile phases and you can directly inject, no need to dry down and reconstitute in high aqueous, like for RPLC
May eliminate some solubility issues
Enhanced detection sensitivity with MS
Efficient spraying and de-solvation in electrospray MS
8
Advantage of HILIC: Peak Shape, Retention of
Basic Compounds
LC/MS/MS Separation of Paroxetine and Ranitidine
Paroxetine
Antidepressant
MW 329.36
Ranitidine
Antiulcerative
MW 314.41
OO
NF
O
S
N NO
N
NO2
Basic portion of molecule, impacts HILIC retention
9
LC/MS/MS Separation of Paroxetine and Ranitidine
Advantage of HILIC: Peak Shape, Retention of
Basic Compounds
min 2 4 6 8 10 12
6 2 4 8 10 12 min
Agilent ZORBAX XDB-C18, 2.1 x 150 mm
Mobile phase: 5-90% B in 10 min
Agilent ZORBAX Rx-Sil, 2.1 x 150 mm
Mobile phase: 100-50% B in 10 min
Agilent 1100 Series LC System
Agilent 1100 Series LC/MSD Trap
A: 8 mM ammonium formate
B: 8 mM ammonium formate in acetonitrile /
water (95:5)
0.3 mL/min
Gradient elution
Injection Volume: 5 µL of 100 ppb sample
Column: 40 oC
MS: ESI+, MRM, 350 oC, 10 L/min, 45 psi
Sample:
Paroxetine, m/z 330192
Ranitidine, m/z 315176
Improved retention, peak
shape and sensitivity for
ranitidine in HILIC mode
10
Disadvantages of HILIC
Mechanism not entirely understood; mixed mechanisms
Column overloading can be a problem
Similar to silanol overloading in RPLC
Overloaded HILIC peaks show fronting
Equilibration times can be long for certain column types
Particularly true for bare silica columns – take longer to
equilibrate initially, will take longer to equilibrate when
mobile phase changes for gradients or method
development are required
Cannot inject strong solvent (H2O, CH3OH) without distorting
peaks
11
LC/UV Separation of Nucleobases
Disadvantage of HILIC: Column Equilibration and
Re-equilibration
min 2 4 6 8 10 12 14 16
mAU
0
50
100
150
200
250
min 2 4 6 8 10 12 14 16
mAU
0
50
100
150
200
250
Agilent 1200 Series Quat LC System
Agilent ZORBAX Rx-Sil, 2.1 x 150 mm, 5 µm
A: 25 mM ammonium acetate with 2.5 mM
ammonium formate
B: acetonitrile
0.1 mL/min
Isocratic elution, 90% B
Injection Volume: 0.5 µL of 0.4 mg/mL
sample
Column: 25 oC
DAD: Sig=254,4nm, Ref=360,100nm; 1 s
data collection rate; flow cell 3 mm, 2 µL
Sample:
Thymine, Uracil, Adenine, Guanine, Cytosine
Equilibration is quicker
when changing from
high to low aqueous
Equilibrating from 80 to 90% acetonitrile:
WORKS
Equilibrating from 95 to 90% acetonitrile:
DOES NOT WORK
12
LC/MS Separation of Vitamin B Related Compounds
Disadvantage of HILIC: Injection Solvent Effects
with H2O and CH3OH
x102
0
0.5
1 H2O
x102
0
0.5
1 H2O/CH3CN (1:1)
x102
0
0.5
1 CH3CN
Counts (%) vs. Acquisition Time (min)
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9
x102
0
0.5
1 CH3OH
x102
0
0.5
1 CH3OH/CH3CN (1:1)
PW1/2 = 0.021
PW1/2 = 0.024 PW1/2 = 0.048
PW1/2 = 0.019
PW1/2 = 0.113
PW1/2 = 0.107 PW1/2 = 0.056
PW1/2 = 0.016
PW1/2 = 0.064
PW1/2 = 0.047 PW1/2 = 0.050
PW1/2 = 0.017
PW1/2 = 0.023
PW1/2 = 0.031 PW1/2 = 0.049
PW1/2 = 0.016
PW1/2 = 0.026
PW1/2 = 0.044 PW1/2 = 0.054
PW1/2 = 0.014
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
Agilent ZORBAX RRHD HILIC Plus 2.1 x 50
mm, 1.8 µm
Acetonitrile / 100 mM ammonium formate pH
3.2 (9:1)
0.4 mL/min, Pressure: 135 bar
Isocratic elution
Injection Volume: 1 µL of 5 µg/mL sample
Column: 25 oC
MS: ESI+, SIM, 200 oC, 10 L/min, 30 psi,
4000 V, 15 ms dwell time
Sample:
4-Aminobenzoic acid, m/z 138 (Frag 110 V)
Nicotinamide, m/z 123 (Frag 130 V)
Riboflavin, m/z 377 (Frag 160 V)
Nicotinic acid, m/z 124 (Frag 130 V)
Strong injection solvents
negatively affect peak
shape and retention
13
Electrospray Ionization Mass Spectrometry with
HILIC
Eluent is dispersed by electrospray into fine aerosol
Ion formation involves extensive evaporation
Volatile mobile phases needed
Acetonitrile or methanol
Compounds that increase conductivity are commonly added to
mobile phase
Also need to be volatile (formates, acetates, etc)
HILIC is a good match for ESI-MS
Typically uses highly organic, volatile mobile phases
14
HILIC versus RPLC Example
LC/MS Separation of Morphine and its Metabolites
Morphine
Opiate analgesic
MW 285.34
Morphine-3-β-D-glucuronide (M3G)
Non-active metabolite
MW 461.46
Normorphine
Intermediate
MW 271.312
Morphine-6-β-D-glucuronide (M6G)
Major active metabolite
MW 461.46
15
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
Counts (%) vs. Acquisition Time (min)
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3 1.4
Improved LC/MS Performance with UHPLC
Columns
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
A: 10 mM ammonium formate pH 3.2
B: acetonitrile / 100 mM ammonium formate
pH 3.2 (9:1)
0.4 mL/min
Isocratic elution, 10% B
Injection Volume: 2 µL
Column: 25 oC
MS: ESI+, SIM, 250 oC, 11 L/min, 30 psi,
4000 V, 200 V delta EMV, 20 ms dwell time
Sample:
Normorphine, m/z 272
Morphine, m/z 286
Morphine-6-β-D-glucuronide (M6G), m/z 462
Morphine-3-β-D-glucuronide (M3G), m/z 462
Selectivity maintained
across particle sizes;
peak width is improved
with smaller particles
Agilent ZORBAX Eclipse Plus C18, 2.1 x 100 mm, 5 µm
Pressure: 90 bar
Agilent ZORBAX Eclipse Plus C18, 2.1 x 100 mm, 3.5 µm
Pressure: 160 bar
Agilent ZORBAX RRHD Eclipse Plus C18, 2.1 x 100 mm, 1.8 µm
Pressure: 480 bar
16
2 x10
0
0.2
0.4
0.6
0.8
1 1 1
2 x10
0
0.2
0.4
0.6
0.8
1 1 1
2 x10
0
0.2
0.4
0.6
0.8
1 1 1
Counts (%) vs. Acquisition Time (min)
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3 1.4
Improved LC/MS Performance with UHPLC
Columns
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
A: 10 mM ammonium formate pH 3.2
B: acetonitrile / 100 mM ammonium formate
pH 3.2 (9:1)
0.4 mL/min
Isocratic elution, 10% B
Injection Volume: 2 µL
Column: 25 oC
MS: ESI+, SIM, 250 oC, 11 L/min, 30 psi,
4000 V, 200 V delta EMV, 20 ms dwell time
Sample:
Normorphine, m/z 272
Morphine, m/z 286
Morphine-6-β-D-glucuronide (M6G), m/z 462
Morphine-3-β-D-glucuronide (M3G), m/z 462
5x increase in S/N with
1.8 µm compared to 5
µm
S/NM6G = 7.7
S/NM6G = 15.2
S/NM6G = 37.5
Agilent ZORBAX Eclipse Plus C18, 2.1 x 100 mm, 5 µm
Pressure: 90 bar
Agilent ZORBAX Eclipse Plus C18, 2.1 x 100 mm, 3.5 µm
Pressure: 160 bar
Agilent ZORBAX RRHD Eclipse Plus C18, 2.1 x 100 mm, 1.8 µm
Pressure: 480 bar
17
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
Counts (%) vs. Acquisition Time (min)
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3 1.4
HILIC versus RPLC: Column Selectivity
Agilent ZORBAX RRHD Eclipse Plus C18, 2.1 x 100 mm, 1.8 µm
Mobile phase: 10% B
Pressure: 480 bar
Agilent ZORBAX RRHD HILIC Plus, 2.1 x 100 mm, 1.8 µm
Mobile phase: 70% B
Pressure: 350 bar
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
A: 10 mM ammonium formate pH 3.2
B: acetonitrile / 100 mM ammonium formate
pH 3.2 (9:1)
0.4 mL/min
Isocratic elution
Injection Volume: 2 µL
Column: 25 oC
MS: ESI+, SIM, 250 oC, 11 L/min, 30 psi,
4000 V, 200 V delta EMV, 20 ms dwell time
Sample:
Normorphine, m/z 272
Morphine, m/z 286
Morphine-6-β-D-glucuronide (M6G), m/z 462
Morphine-3-β-D-glucuronide (M3G), m/z 462
Complimentary
selectivity between a
HILIC column and a C18
18
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
Counts (%) vs. Acquisition Time (min)
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3 1.4
HILIC versus RPLC: ESI-MS Sensitivity
Agilent ZORBAX RRHD Eclipse Plus C18, 2.1 x 100 mm, 1.8 µm
Mobile phase: 10% B
Pressure: 480 bar
Agilent ZORBAX RRHD HILIC Plus, 2.1 x 100 mm, 1.8 µm
Mobile phase: 70% B
Pressure: 350 bar
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
A: 10 mM ammonium formate pH 3.2
B: acetonitrile / 100 mM ammonium formate
pH 3.2 (9:1)
0.4 mL/min
Isocratic elution
Injection Volume: 2 µL
Column: 25 oC
MS: ESI+, SIM, 250 oC, 11 L/min, 30 psi,
4000 V, 200 V delta EMV, 20 ms dwell time
Sample:
Normorphine, m/z 272
Morphine, m/z 286
Morphine-6-β-D-glucuronide (M6G), m/z 462
Morphine-3-β-D-glucuronide (M3G), m/z 462
More efficient spraying
and de-solvation in ESI-
MS with HILIC mode
than with RPLC
19
HILIC versus RPLC: ESI-MS Sensitivity
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
A: 10 mM ammonium formate pH 3.2
B: acetonitrile / 100 mM ammonium formate
pH 3.2 (9:1)
0.4 mL/min
Isocratic elution
Injection Volume: 2 µL
Column: 25 oC
MS: ESI+, SIM, 250 oC, 11 L/min, 30 psi,
4000 V, 200 V delta EMV, 20 ms dwell time
Sample:
Normorphine, m/z 272
Morphine, m/z 286
Morphine-6-β-D-glucuronide (M6G), m/z 462
Morphine-3-β-D-glucuronide (M3G), m/z 462
4x Improvement in S/N
for M6G in HILIC mode
Agilent ZORBAX RRHD Eclipse Plus C18
2.1 x 100 mm, 1.8 µm
Mobile phase: 10% B
Pressure: 480 bar
Agilent ZORBAX RRHD HILIC Plus
2.1 x 100 mm, 1.8 µm
Mobile phase: 70% B
Pressure: 350 bar
S/NM6G = 37.5
S/NM6G = 143.9
20
HILIC with UHPLC/MS versus RPLC with LC/MS:
ESI-MS Sensitivity
S/NM6G = 143.9
Agilent ZORBAX Eclipse Plus C18
2.1 x 100 mm, 5 µm
Mobile phase: 10% B
Pressure: 90 bar
Agilent ZORBAX RRHD HILIC Plus
2.1 x 100 mm, 1.8 µm
Mobile phase: 70% B
Pressure: 350 bar
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
A: 10 mM ammonium formate pH 3.2
B: acetonitrile / 100 mM ammonium formate
pH 3.2 (9:1)
0.4 mL/min
Isocratic elution
Injection Volume: 2 µL
Column: 25 oC
MS: ESI+, SIM, 250 oC, 11 L/min, 30 psi,
4000 V, 200 V delta EMV, 20 ms dwell time
Sample:
Normorphine, m/z 272
Morphine, m/z 286
Morphine-6-β-D-glucuronide (M6G), m/z 462
Morphine-3-β-D-glucuronide (M3G), m/z 462
20x improvement in S/N
with HILIC as compared
to RPLC
S/NM6G = 7.7
21
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 Agilent ZORBAX Eclipse Plus C18, 2.1 x 100 mm, 5 µm
Mobile phase: 10% B
0.4 mL/min
Pressure: 90 bar
2 x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1
Counts (%) vs. Acquisition Time (min)
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3 1.4
HILIC with UHPLC/MS versus RPLC with LC/MS:
Analysis Time and ESI-MS Sensitivity
S/NM6G = 7.7
S/NM6G = 100.4
Agilent ZORBAX RRHD HILIC Plus, 2.1 x 100 mm, 1.8 µm
Mobile phase: 70% B
1 mL/min
Pressure: 810 bar
Agilent 1290 Infinity LC System
Agilent 6410A LC/MS
A: 10 mM ammonium formate pH 3.2
B: acetonitrile / 100 mM ammonium formate
pH 3.2 (9:1)
0.4 mL/min
Isocratic elution
Injection Volume: 2 µL
Column: 25 oC
MS (0.4/1 mL/min): ESI+, SIM, 250/325 oC,
11/12 L/min, 30/55 psi, 4000 V, 200 V delta
EMV, 20/10 ms dwell time
Sample:
Normorphine, m/z 272
Morphine, m/z 286
Morphine-6-β-D-glucuronide (M6G), m/z 462
Morphine-3-β-D-glucuronide (M3G), m/z 462
>10x more sensitivity in
half the time with HILIC
and UHPLC/MS
22
Conclusions
HILIC provides good peak shape and retention for polar compounds
HILIC uses highly organic mobile phases
Volatility allows for more efficient spraying in ESI-MS, can increase
MS sensitivity by 4x compared to a similar RPLC analysis
Low viscosity permits faster flow rates allowed with UHPLC columns
and LC systems, resulting in analyses accomplished in less time,
while sub-2-µm columns still improve MS S/N compared to RPLC
Sub-2-µm UHPLC columns can improve MS sensitivity by 5x compared to
traditional 5 µm columns, while maintaining the same selectivity
Transferring a method from RPLC mode with a traditional 5 µm column to
HILIC mode with a UHPLC column can improve MS sensitivity by 20x
23